Managing Sleep-wake Disruption Due to Hospitalisation: the Circadian Care Project — CircadianCare  

Circadian Rhythm Disorders Clinical Trial

Official title: Managing Sleep-wake Disruption Due to Hospitalisation: the Circadian Care Project

Status Recruiting

Clinical Trial Summary

Sleep is regulated by the interaction of homeostatic and circadian processes. The homeostatic process determines sleep propensity in relation to sleep-wake history, the circadian one is responsible for the alternation of high/low sleep propensity in relation to dark/light cues, and is substantially independent of preceding sleep-wake behaviour. The circadian timing system encompasses a master clock in the brain and peripheral, ancillary time-keepers in virtually every organ of the body. In recent years, evidence has emerged that circadian disruption has serious medical consequences, including sleep loss, increased cardiovascular morbidity and increased risk of certain types of cancer. Evidence is also emerging that hospitalization per se weakens circadian rhythmicity, due to disease itself and to modified light, food and activity cues. The aim of our project is to test an inpatient management system (CircadianCare) that limits the circadian impact of hospitalisation by enhancing circadian rhythmicity through an assessment of the patient's specific circadian features/needs and an ad hoc, personalized light-dark, meal and activity schedule to cover the whole of the inpatient stay. This will be compared to standard inpatient management in terms of patients' perception, sleep-wake quality and timing during hospitalisation, inpatient utilization of sleep-inducing medication, length of hospitalisation, and prognosis (i.e. outcome of hospitalisation, subsequent hospitalisations and post-discharge sleep-wake disturbances). The CircadianCare system is expected to benefit prognosis, decrease costs, and change the way hospitals are organized and designed in future, with potential direct relevance to the plans for the new University Hospital of Padova.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Chronobiology Disorders
• Circadian Rhythm Disorders

• NCT number: NCT05228444
• Study type: Interventional
• Source: University Hospital Padova
• Contact: Sara Montagnese
• Phone: +390498218675
• Email: sara.montagnese@unipd.it
• Status: Recruiting
• Phase: N/A
• Start date: October 28, 2020
• Completion date: January 28, 2023